Complications of Pregnancy
RSSArticles
-
More Promise from Olaparib in Recurrent Ovarian Cancer: The BRCA Cohort
Olaparib, a poly (ADP)-ribose polymerase (PARP) inhibitor, demonstrated substantial delay until progression when administered to women as a maintenance therapy with BRCA-mutant recurrent ovarian cancer. -
AMH: Marker of Ovarian Reserve and More
Serum anti-Mullerian hormone (AMH) has been well-established as an accurate marker of ovarian reserve. It is solely produced in the human ovary by the granulosa cells. -
Do Patients Need Routine Pelvic Exams?
A review of the published literature finds no value to the routine screening pelvic examination in asymptomatic non-pregnant women. -
Endometriosis-Associated Ovarian Carcinoma (EAOC)
-
Management of Women with Atypical Pap Tests of Undetermined Significance
-
Postmenopausal Hormone Therapy and Stroke. WEST: The Women’s Estrogen for Stroke Trial
-
Special Feature: Enlightened Management of IUGR
-
Treatment of Vulvar Vestibulitis with Submucous Infiltrations of Methylprednisolone and Lidocaine
-
Ask questions to assess teens’ condom knowledge
-
Teens often misinformed about proper condom use